The Global Fund to Fight AIDS, Tuberculosis and Malaria is facing a budget shortfall of about $3 billion, Marcela Rojo, a Global Fund spokesperson, said on Friday, Reuters reports.
Recent Releases: TB Plans Compared; Seasonal Hunger; Getting Health Workers In Underserved Places; Antiretroviral Drugs To Prevent HIV
Economic Benefits Of Global Plan To Stop TB Examined A study, recently published in the journal Health Affairs, analyzes the costs associated with the Global Plan to Stop TB and compared them to the cost of sustaining the DOTS treatment program. The study finds that the “economic benefits” of the…
HIV-Positive Babies More Likely To Contract Deadly TB If Given BCG A three-year study in South Africa found that babies who were born HIV-positive had a higher risk of contracting a deadly form of tuberculosis if given the widely used BCG vaccine, the AP/Seattle Post-Intelligencer reports. The study, which was…
Also In Global Health News: Developing Country Agriculture; MDR-TB In Pakistan, HIV/AIDS Funding In Ghana; Rwandan Religious Groups Fighting Disease; Trafficked Nigerian Girls Found
Oxfam Calls On G8 Leaders To Increase Agriculture Investment In Developing Countries The development group Oxfam is calling on G8 leaders, ahead of their meeting in Italy, to increase investment in agriculture in developing countries, Reuters reports. The group recently released a report, which shows that agricultural assistance by G8…
On the News Hour Insider Forum, Ray Suarez interviews global health experts Michele Moloney-Kitts, assistant U.S. global AIDS coordinator, and Christine Lubinski, head of the Center for Global Health Policy and Advocacy about President Obama’s $63 billion global health initiative.
The journal Lancet Infectious Diseases examines the worldwide spread of extensively drug-resistant tuberculosis (XDR-TB).
Some Pacific Health Summit attendees said more action should have come from the tuberculosis-focused conference, which ended on Thursday in Seattle, Seattle Times’ “Business of Giving” blog reports.
The pharmaceutical company Tibotec said it will join with the non-profit Global Alliance for Tuberculosis Development (TB Alliance) to speed up the development of the experimental TB drug TMC207, Health-e/IOL reports.
South African AIDS activist Thembi Ngubane recently died of drug-resistant tuberculosis at the age of 24, the AP/Washington Post reports.
Recent Releases: HIV Prevention; Clinical Trials Debate; Definition Of Global Health; Drug Resistant TB
Future Studies Needed To Determine If ‘Test And Treat’ Approach Could ‘End HIV Pandemic Within 50 Years,’ Researchers Say In a Journal of the American Medical Association commentary piece, Anthony Fauci and Carl Dieffenbach of the National Institute of Allergy and Infectious Diseases explore results from a WHO mathematical model…